SCHEMBL19964535

SCHEMBL19964535

O=c1cc(CO)sc2ccc(Br)cc12

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 3/20 0.40
PTPN2 P17706 2/20 0.39
EPM2A O95278 1/20 0.39
PTPN1 P18031 1/20 0.39
PTPN22 Q9Y2R2 1/20 0.39
PIM1 P11309 2/20 0.36
PIM2 Q9P1W9 1/20 0.36
LMNA P02545 1/20 0.36
HPGD P15428 1/20 0.36
GABRP O00591 4/20 0.36
GABRD O14764 4/20 0.36
GABRA1 P14867 4/20 0.36
GABRB1 P18505 4/20 0.36
GABRG2 P18507 4/20 0.36
GABRB3 P28472 4/20 0.36
GABRA5 P31644 4/20 0.36
GABRA3 P34903 4/20 0.36
GABRA2 P47869 4/20 0.36
GABRB2 P47870 4/20 0.36
GABRA4 P48169 4/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19953355 0.83 MIF (0.37) CYP2A6PTPN2EPM2APTPN1PTPN22
SCHEMBL19953210 0.83 CYP2A6 (0.46) CYP2A6PTPN2EPM2APTPN1PTPN22
SCHEMBL1193947 0.77 ALDH1A1 (0.59) CYP2A6LMNAHPGDALDH1A1ALOX15
SCHEMBL19953212 0.76 KAT2B (0.37) CYP2A6PTPN2EPM2APTPN1PTPN22
SCHEMBL3051489 0.75 CYP2A6 (0.58) CYP2A6PTPN2LMNA
SCHEMBL31095741 0.75 CYP2A6 (0.58) CYP2A6PTPN2LMNA
SCHEMBL19953250 0.73 GPR35 (0.42) CYP2A6PTPN2EPM2APTPN1PTPN22
SCHEMBL1530454 0.72 CYP2A6 (0.58) CYP2A6PTPN2LMNAALDH1A1
SCHEMBL29466898 0.70 KDM4E (0.48) CYP2A6PTPN2EPM2APTPN1PTPN22
SCHEMBL5019781 0.70 KDM4E (0.48) CYP2A6PTPN2EPM2APTPN1PTPN22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018048930-A1 LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF PHARMAKEA, INC. (US) 2018-03-15 WO disclosed